Zynex Reports Neil Friery Appointed President and COO of Monitoring Solutions Division

Prevail Drug Coated Balloon Catheter Launches in Europe

Prevail Drug coated balloon catheter is used during percutaneous coronary intervention procedures to treat narrowed or blocked coronary arteries in patients with coronary artery disease.

VERITAS Vision System Is Introduced by Johnson & Johnson

The company will offer live demos of the new system in a wet lab at the Johnson & Johnson booth (#2813) this weekend at the 2021 American Society of Cataract and Refractive Surgery and American Society of Ophthalmic Administrators Annual Meeting.

October 23, 2020

Zynex, Inc. a medical technology company specializing in the manufacture and sale of non-invasive medical devices for pain management, stroke rehabilitation, cardiac monitoring and neurological diagnostics today announced that it has hired Neil Friery as the President and Chief Operating Officer (COO) of its Monitoring Solutions Division.

Zynex reports as President and COO, Neil will lead operations, sales, marketing and product development of the Monitoring Solution Division including the production and launch of the CM-1500 Blood Volume Monitor which was granted 510(k) clearance by the U.S. Food and Drug Administration earlier this year.

Thomas Sandgaard, founder and CEO said: “I am excited to bring Neil in to run our Monitoring Solutions Division. We continue to build out this division, adding personnel in clinical research and sales and marketing. With Neil’s background, I am confident we will soon have our technology become the standard-of-care for early detection of internal bleeding in surgical and post-surgical recovery.  While the CM-1500 is already in full production, the next generation (CM-1600) is well underway and we hope to apply for FDA clearance for that model soon.”

Neil Friery previously worked as a Senior Vice President and General Manager at Zimmer Biomet, leading the Surgical Division of this Fortune 500 musculoskeletal healthcare company.  During his tenure at Zimmer Biomet, Neil oversaw all functional aspects of the Surgical organization and was instrumental in the build-out of a direct sales force, several new product launches, as well as strategic acquisitions and distribution agreements doubling the division’s revenue to $400M. Prior to his appointment as Senior Vice President and General Manager, Neil was the Director of Finance for the Surgical Division.

Neil graduated with honors from the University of Notre Dame with a Bachelor of Business Administration. Neil is currently an Entrepreneur in Residence at Case Western Reserve University and a member of the Board of Director’s at the West Side Catholic Center.

spot_img

DON'T MISS

Asensus Surgical Appoints Two New Board Members

Asensus Surgical, Inc. (NYSE American: ASXC), a medical device company that is digitizing the interface between the surgeon and the patient to pioneer a new era of Performance-Guided Surgery™, today announced the expansion of its Board of Directors, appointing...

Our Sister Publication: Biotechnology News Magazine

Subscribe to Medical Device News Magazine here.